BNP Paribas Financial Markets
IMNM icon

BNP Paribas Financial Markets’s Immunome IMNM Stock Holding History

BNP Paribas Financial Markets’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.62M Sell
359,780
-2,841
-0.8% -$60.8K ﹤0.01% 1802
2026
Q1 		$7.93M Buy
362,621
+351,491
+3,158% +$7.82M ﹤0.01% 1702
2025
Q4 		$239K Sell
11,130
-3,999
-26% -$70.2K ﹤0.01% 3976
2025
Q3 		$177K Buy
15,129
+8,665
+134% +$86.2K ﹤0.01% 4064
2025
Q2 		$60.1K Buy
6,464
+2,909
+82% +$23.9K ﹤0.01% 4184
2025
Q1 		$23.9K Sell
3,555
-3,029
-46% -$29.1K ﹤0.01% 4489
2024
Q4 		$69.9K Buy
+6,584
New +$79.6K ﹤0.01% 4305
2022
Q4 		– Sell
-67
Closed -$297 – 4309
2022
Q3 		$297 Buy
+67
New +$314 ﹤0.01% 4572

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

BNP Paribas Financial Markets's IMNM Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its Immunome (IMNM) stake by 0.78% in Q2 2026, selling an estimated $60.8K and leaving 359,780 shares worth $7.62M. The position accounts for ﹤0.01% of the portfolio, ranked #1802.

BNP Paribas Financial Markets first reported a position in IMNM in Q3 2022 and has held it in 8 quarters since. The position peaked at $7.93M in Q1 2026. 188 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • BNP Paribas Financial Markets held 359,780 shares of Immunome worth $7.62M as of Q2 2026.
  • BNP Paribas Financial Markets sold 2,841 Immunome shares in Q2 2026, an estimated $60.8K.
  • Immunome made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #1802 holding.
  • BNP Paribas Financial Markets first reported a position in Immunome in Q3 2022 and has held it in 8 quarters since.
  • BNP Paribas Financial Markets's Immunome position peaked at $7.93M in Q1 2026.
  • 188 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.